Evidence map›Paper›PMID 34582649›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2021

Impact of Screening on Breast Cancer Incidence in Kazakhstan: Results of Component Analysis.

Assem Toguzbayeva, Zhansaya Telmanova, Arman Khozhayev, Aizhan Jakipbayeva, Gulshara Aimbetova, Akmaral Zhantureyeva, Zarina Bilyalova, Saltanat Urazova, Gulnur Igissinova, Botagoz Turdaliyeva and 2 more

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Evaluation of a National Breast Cancer Screening Program in a Middle-Income Country: The Case of Kazakhstan.International journal of environmental research and public health · 2026
    Article
  2. Article
  3. Article
  4. Trends in Stage-Specific Kidney Cancer Incidence in Kazakhstan, 2005-2019.Asian Pacific journal of cancer prevention : APJCP · 2024
    Article
  5. Association of Gene Polymorphisms with Breast Cancer Risk in the Kazakh Population.Asian Pacific journal of cancer prevention : APJCP · 2023
    Article
  6. Article
  7. Study on Breast Cancer in Kazakhstan Using the Functional Time Series.Asian Pacific journal of cancer prevention : APJCP · 2023
    Article
  8. Corpus Uteri Cancer in Kazakhstan: Recent Incidence Trends.Asian Pacific journal of cancer prevention : APJCP · 2023
    Article
  9. Article
  10. Article
  11. Breast Cancer Incidence in Kyrgyzstan: Report of 15 Years of Cancer Registry.Asian Pacific journal of cancer prevention : APJCP · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Assem ToguzbayevaAsfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Zhansaya TelmanovaCentral Asian Cancer Institute, Nur-Sultan, Kazakhstan.ORCID 0000-0002-2364-6520
Arman KhozhayevAsfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.ORCID 0000-0002-0499-5258
Aizhan JakipbayevaAsfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.ORCID 0000-0002-3221-9758
Gulshara AimbetovaAsfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.ORCID 0000-0002-9466-6297
Akmaral ZhantureyevaAstana Medical University, Nur-Sultan, Kazakhstan.ORCID 0000-0003-4166-544X
Zarina BilyalovaCentral Asian Cancer Institute, Nur-Sultan, Kazakhstan.ORCID 0000-0002-0066-235X
Saltanat UrazovaCentral Asian Cancer Institute, Nur-Sultan, Kazakhstan.ORCID 0000-0002-2331-1261
Gulnur IgissinovaAsfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.ORCID 0000-0001-6881-2257
Botagoz TurdaliyevaKazakh Medical University of Continuing Education, Almaty, Kazakhstan.ORCID 0000-0001-6884-0777
Malcolm Anthony MooreEurasian Institute for Cancer Research, Bishkek, Kyrgyzstan.
Nurbek Saginbekovich IgissinovCentral Asian Cancer Institute, Nur-Sultan, Kazakhstan.ORCID 0000-0002-2517-6315

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe study is to conduct a component analysis of the dynamics of the incidence of BC (BC) in Kazakhstan, taking into account regions.

methodsPrimary data were for registered patients with BC (ICD 10 - C50) in the whole country during the period of 2009-2018. Evaluation of changes in BC incidence in the population of Kazakhstan was performed using component analysis according to the methodological recommendations.

resultsThe study period, 40,199 new cases of BC were recorded. The incidence rate increased from 39.5 (2009) to 49.6 in 2018 and the overall growth was 2.8 per 100,000 population of female, including due to the age structure - ∑ΔA=+2.99, due to the risk of acquiring illness - ∑ΔR=+6.82 and their combined effect - ∑ΔRA=+0.31. The component analysis revealed that the increase in the number of patients with BC was mainly due to the growth of the population (ΔP=+31.1%), changes in its age structure (ΔA=+18.0%) and changes associated with the risk of acquiring illness (ΔR=+41.0%). The increase in the number of patients in the regions of the republic is associated with the influence of demographic factors and with risk factors for getting sick, including mammographic screening.

conclusionThus, as a result of the component analysis, the role of the influence of demographic factors and the risk of acquiring illness on the formation of the number of patients and the incidence of BC was evaluated, while geographical variability was established. This research was the first epidemiological study of the dynamics of BC in the regional context by the method of component analysis in the population of Kazakhstan. The implementation of the results of this study is recommended in management of anticancer activities for BC.

Indexed as

AdolescentAdultAgedAged, 80 and overBreast NeoplasmsFemaleHumansIncidenceKazakhstanMass ScreeningMiddle AgedYoung Adultbreast cancerComponent analysisIncidenceKazakhstanScreening

Identifiers

PMID34582649
PMCPMC8850875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.